샘플 요청 목록

 카트 문의
시장보고서
상품코드
1486835

일주기 리듬 수면장애 시장 : 인사이트, 경쟁 환경 및 시장 예측(2030년)

Circadian Rhythm Sleep Disorders - Market Insights, Competitive Landscape and Market Forecast-2030
발행일: | 리서치사: DelveInsight | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

세계 일주기 리듬 수면장애 시장 규모는 2023년 7억 6,123만 달러에 달했습니다. 이 시장은 2024년부터 2030년까지 예측 기간 동안 연평균 6.88% 성장하여 2030년에는 12억 886만 달러에 달할 것으로 예상됩니다. 일주기 리듬 수면 장치 및 약물에 대한 수요는 주로 수면장애의 유병률 증가에 의해 주도되고 있습니다. 이 수면장애는 높은 스트레스 수준, 불규칙한 근무 일정, 과도한 스크린 시간, 알코올 및 카페인 섭취 증가 등 여러 요인의 영향을 받습니다. 또한, 노인 인구 증가와 양질의 수면의 이점을 강조하는 수면 교육 캠페인 증가도 2024-2030년의 예측 기간 동안 시장 성장에 기여하는 주요 요인 중 하나입니다.

미국 질병통제예방센터(Centers for Disease Control and Prevention 2023)가 제공한 데이터에 따르면, 2021년 미국 성인 인구 약 2,830만 명 중 약 11.5%가 담배를 피우는 것으로 추정됩니다. 담배에 함유된 니코틴은 수면 패턴을 방해하고 수면장애를 일으킬 가능성을 높입니다. 흡연 증가는 불면증과 일주기 수면장애와 같은 수면장애의 유병률을 증가시키는 경향이 있으며, 이는 일주기 수면장애 치료제 시장의 긍정적인 성장에 영향을 미칠 것으로 보입니다.

수면장애 증가의 또 다른 중요한 요인은 스크린 사용 시간 증가와 노동 시간의 연장입니다. 2023년 경제협력개발기구(OECD)에 따르면 미국의 1인당 연간 평균 노동 시간은 1,791시간에 달하고, 2021년 OECD 평균 1,716시간을 넘어설 것으로 예상됩니다. 일본 역시 OECD 평균인 10%에 비해 유급직 종사자 중 장시간 근무하는 비율이 높은 것으로 추정됩니다. 이러한 장시간 노동은 수면 부족을 초래하고 전반적인 삶의 질을 떨어뜨려 수면장애의 유병률 증가에 일조하고 있습니다. 따라서 예측 기간 동안 일주기 리듬 수면장애 치료 시장의 성장에 긍정적인 영향을 미칠 것으로 예상됩니다.

이 보고서는 세계 일주기 리듬 수면장애 시장을 조사했으며, 시장 개요와 함께 제품 유형별/용도별/최종사용자별/지역별 동향, 시장 진출기업 프로파일 등의 정보를 제공합니다.

목차

제1장 일주기 리듬 수면장애 시장 보고서 서론

제2장 일주기 리듬 수면장애 시장 주요 요약

  • 시장 개요

제3장 경쟁 구도

제4장 규제 분석

  • 미국
  • 유럽
  • 일본
  • 중국

제5장 일주기 리듬 수면장애 시장의 주요 요인 분석

  • 일주기 리듬 수면장애 시장 성장 촉진요인
  • 일주기 리듬 수면장애 시장 성장 억제요인과 과제
  • 일주기 리듬 수면장애 시장 기회

제6장 일주기 리듬 수면장애 시장 : Porter의 Five Forces 분석

제7장 일주기 리듬 수면장애 시장 레이아웃

  • 제품 유형별
  • 용도별
  • 최종사용자별
  • 지역별

제8장 일주기 리듬 수면장애 시장 기업과 제품 개요

  • Koninklijke Philips N.V.
  • The Sunbox Company
  • Northern Light Technologies
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.
  • Pfizer Inc.
  • VANDA PHARMACEUTICALS
  • Nature's Bounty
  • Verilux, Inc.
  • OLLY Vitamins & Supplements
  • Pure Encapsulations, LLC
  • Vespyr Brands
  • NOW FOODS
  • Natrol, LLC.
  • Pharmavite LLC
  • Relaxium
  • Amazon Basics
  • Future Kind
  • Apollo Light Systems

제9장 KOL(Key Opinion Leader)의 견해

제10장 프로젝트 접근

제11장 DelveInsight에 대해

제12장 면책사항과 문의

LSH 24.06.05

Circadian Rhythm Sleep Disorders Market By Product Type (Device And Therapeutics), Application (Delayed Sleep-Wake Phase Disorder, Advanced Sleep-Wake Phase Disorder, Irregular Sleep Wake Rhythm, And Others), End-User (Hospitals, Sleep Clinics, Homecare, And Others) and geography is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of sleep disorders and increase in sleep awareness campaigns highlighting the advantages of high-quality sleep

The global circadian rhythm sleep disorders market was valued at USD 761.23 million in 2023, growing at a CAGR of 6.88% during the forecast period from 2024 to 2030 to reach USD 1,208.86 million by 2030. The demand for Circadian Rhythm Sleep devices and drugs is primarily being boosted by the rising prevalence of sleep disorders, which is influenced by many factors such as high stress levels, irregular work schedules, excessive screen time, and increasing consumption of alcohol and caffeine. Additionally, the rising geriatric population and increase in sleep awareness campaigns highlighting the advantages of high-quality sleep are some of the key factors that are contributing to the growth of the market during the forecast period from 2024-2030.

Circadian Rhythm Sleep Disorders Market Dynamics:

As per the data provided by the Centers for Disease Control and Prevention 2023, it was estimated that around 11.5% of people which accounted for around 28.3 million US adults were smoking cigarettes in the year 2021. Nicotine, found in tobacco, disrupts sleep patterns and increases the likelihood of developing sleep disorders. The rise in smoking will tend to increase the prevalence of sleep disorders such as insomnia and circadian rhythm sleep disorders, which will in return result in the positive growth of the Circadian Rhythm Sleep Disorders treatment market.

Another significant contributor to the rising sleep disorders is the escalation in screen time and extended working hours. According to the Organization for Economic Co-operation and Development (OECD) in 2023, the average annual hours worked per employee in the US reached 1,791, surpassing the 2021 OECD average of 1,716 hours per worker. Similarly, in Japan, a higher percentage of employees work excessively long hours in paid employment compared to the OECD average of 10%. These prolonged working hours contribute to sleep deprivation and diminish overall quality of life, thus contributing to the rising prevalence of sleep disorders. Therefore, positively influencing the growth of the Circadian Rhythm Sleep Disorders treatment market during the forecast period.

Additionally, an increase in sleep awareness campaigns highlighting the advantages of high-quality sleep by prominent organizations is another key factor accelerating the growth of the circadian rhythm sleep disorders treatment market. For instance, in September 2022, a National Campaign titled "Sleep is Good Medicine" was launched by the American Academy of Sleep Medicine to increase awareness regarding the importance of sleep and its connection to health. Further, in 2022, the Government of the UK launched the Rough Sleeping Initiative and made allocations for the first multi-year funding to provide local councils with long-term funding to support people who were sleeping rough or at risk of rough sleeping. Thus, the rising sleep awareness campaigns will tend to drive the growth of the overall circadian rhythm sleep disorders treatment market during the forecast period.

However, lack of awareness and diagnosis of sleep disorders and side effects associated with bright light therapy devices such as eye strain, headaches, nausea, or irritability, are some of the key constraints that may limit the growth of the Circadian Rhythm Sleep Disorders market.

Circadian Rhythm Sleep Disorders Market Segment Analysis:

Circadian Rhythm Sleep Disorders market by Product Type (Device and Therapeutics), Application (Delayed Sleep-Wake Phase Disorder, Advanced Sleep-Wake Phase Disorder, Irregular Sleep Wake Rhythm, and Others), End-User (Hospitals, Sleep clinics, Homecare, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the Product segment of the circadian rhythm sleep disorders market, the devices category is estimated to amass a significant revenue share in the Circadian Rhythm Sleep Disorders market in 2023. This can be attributed to the various applications provided by these devices such as light therapy devices. Bright light therapy devices are used for the treatment of Circadian Rhythm Sleep Disorders, these devices help to regulate the body's internal clock, known as the circadian rhythm. Exposure to bright light, especially in the morning, can help synchronize the body's natural sleep-wake cycle with the external environment. Bright light therapy is non-invasive and generally well-tolerated by most individuals. Unlike medications or other more invasive treatments, it does not typically have significant side effects when used correctly. This makes it a safe and attractive treatment option for a wide range of people. Further, Bright light therapy can be administered at home or in clinical settings using portable light therapy devices. This offers convenience and flexibility for individuals who may not have access to specialized treatment centers or who prefer the convenience of home-based therapy.

Therefore, owing to the above-mentioned factors, the device category is expected to register significant growth, thereby driving the growth of the overall Circadian Rhythm Sleep Disorders treatment market during the forecast period.

North America Is Expected To Dominate The Overall Circadian Rhythm Sleep Disorders Market:

North America is expected to account for the highest proportion of the Circadian Rhythm Sleep Disorders Market in 2023, out of all regions. This can be attributed to the rising awareness regarding sleep disorders, increasing R&D activities, growing geriatric population, and increasing burden of sleep disorders in the region are some of the contributing factors to the growth of the circadian rhythm sleep disorder treatment market in North America.

According to data published by the Centers of Disease Control and Prevention 2022, it was estimated that approximately 14.5% of adults in the United States in the year 2020, had trouble falling asleep. Thus, the increasing burden of sleep disorders in the United States will eventually create a need for the management and treatment of such sleep disorders, which will further propel the market for the circadian rhythm sleep disorders treatment devices and rugs market in North America.

Further, key players present in the region, such as Pfizer, Northern Light Technologies and The Sunbox Company are currently driving a wide range of initiatives, such as enhancing market access and distribution, making investments in research and development and inking strategic collaborations and partnerships, which will further contribute for the growth of the Circadian Rhythm Sleep Disorders treatment market in North America.

Therefore, the factors mentioned above, are responsible for driving the overall market for circadian rhythm sleep disorders treatment market in North America during the forecast period.

Circadian Rhythm Sleep Disorders Market Key Players:

Some of the key market players operating in the Circadian Rhythm Sleep Disorders market include, Koninklijke Philips N.V., The Sunbox Company, Northern Light Technologies, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Pfizer Inc., VANDA PHARMACEUTICALS, Nature's Bounty, Verilux, Inc., OLLY Vitamins & Supplements, Pure Encapsulations, LLC, Vespyr Brands, NOW FOODS, Natrol, LLC., Pharmavite LLC, and Others.

Recent Developmental Activities In The Circadian Rhythm Sleep Disorders Market:

  • In September 2023, Ritual launched new melatonin sleep supplements to ease sleeping disorders. These melatonin supplements consist of innovative three-in-one capsule technology.
  • In July 2021, Arquimea and Circadian Therapeutics entered into a product development agreement for the development of a molecule (AP-2) for the treatment of several neurodegenerative and circadian rhythm disorders.

Key Takeaways From The Circadian Rhythm Sleep Disorders Market Report Study

  • Market size analysis for current Circadian Rhythm Sleep Disorders Market size (2023), and market forecast for 6 years (2024-2030)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the Circadian Rhythm Sleep Disorders market.
  • Various opportunities available for the other competitors in the Circadian Rhythm Sleep Disorders Market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current Circadian Rhythm Sleep Disorders market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Circadian Rhythm Sleep Disorders market growth in the coming future?

Target Audience Who Can Be Benefited From This Circadian Rhythm Sleep Disorders Market Report Study

Circadian Rhythm Sleep Disorders product providers

Research organizations and consulting companies

Circadian Rhythm Sleep Disorders-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in Circadian Rhythm Sleep Disorders

Various End-users who want to know more about the Circadian Rhythm Sleep Disorders Market and the latest technological developments in the Circadian Rhythm Sleep Disorders market.

Frequently Asked Questions For The Circadian Rhythm Sleep Disorders Market:

1. What is meant by Circadian Rhythm Sleep Disorders?

Circadian Rhythm Sleep Disorders are a group of conditions characterized by disruptions in the body's internal biological clock, known as the circadian rhythm, which regulates the sleep-wake cycle. These disorders result in difficulties falling asleep, staying asleep, or waking up at the desired times, leading to sleep disturbances and impairments in daytime functioning.

2. What is the market for Circadian Rhythm Sleep Disorders?

The circadian rhythm sleep disorders market was valued at USD 761.23 million in 2023, growing at a CAGR of 6.88% during the forecast period from 2024 to 2030 to reach USD 1,208.86 million by 2030.

3. What are the drivers for the global Circadian Rhythm Sleep Disorders market?

The circadian rhythm sleep disorders treatment market is slated to witness prosperity owing to factors such as the rising prevalence of sleep disorders, which is influenced by many factors such as high-stress levels, irregular work schedules, excessive screen, and increasing consumption of alcohol and caffeine. Additionally, the rising geriatric population and increase in sleep awareness campaigns highlighting the advantages of high-quality sleep are some of the key factors that are contributing to the growth of the circadian rhythm sleep disorders treatment market during the forecast period from 2024-2030.

4. Who are the key players operating in the global Circadian Rhythm Sleep Disorders market?

Some of the key market players operating in the Circadian Rhythm Sleep Disorders market Koninklijke Philips N.V., The Sunbox Company, Northern Light Technologies, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Pfizer Inc., VANDA PHARMACEUTICALS, Nature's Bounty, Verilux, Inc., OLLY Vitamins & Supplements, Pure Encapsulations, LLC, Vespyr Brands, NOW FOODS, Natrol, LLC., Pharmavite LLC, and Others.

5. Which region has the highest share in the global Circadian Rhythm Sleep Disorders market?

North America is expected to dominate the overall Circadian Rhythm Sleep Disorders market during the forecast period, 2024 to 2030. This can be attributed to the rising awareness regarding sleep disorders, increasing R&D activities, growing geriatric population and increasing burden of sleep disorders in the region are some of the contributing factors for the growth of circadian rhythm sleep disorders treatment market in North America.

Table of Contents

1. Circadian Rhythm Sleep Disorders Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Circadian Rhythm Sleep Disorders Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Circadian Rhythm Sleep Disorders Market Key Factors Analysis

  • 5.1. Circadian Rhythm Sleep Disorders Market Drivers
    • 5.1.1. Rising prevalence of sleep disorders
    • 5.1.2. Increasing intake of caffeine and alcohol
  • 5.2. Circadian Rhythm Sleep Disorders Market Restraints and Challenges
    • 5.2.1. Lack of awareness and diagnosis of sleep disorders
    • 5.2.2. Side effects associated with light therapy devices
  • 5.3. Circadian Rhythm Sleep Disorders Market Opportunities
    • 5.3.1. Integration of Precision Medicine in the Management of Circadian Rhythm Sleep Disorders

6. Circadian Rhythm Sleep Disorders Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Circadian Rhythm Sleep Disorders Market Layout

  • 7.1. By Product Type
    • 7.1.1. Devices
    • 7.1.2. Therapeutics
  • 7.2. By Application
    • 7.2.1. Delayed Sleep-wake phase Disorder
    • 7.2.2. Advanced Sleep-wake phase Disorder
    • 7.2.3. Irregular Sleep Wake Rhythm
    • 7.2.4. Others
  • 7.3. By End-User
    • 7.3.1. Hospitals
    • 7.3.2. Sleep Clinics
    • 7.3.3. Home care
    • 7.3.4. Others
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. United States Circadian Rhythm Sleep Disorders Market Size in USD million (2021-2030)
      • 7.4.1.2. Canada Circadian Rhythm Sleep Disorders Market Size in USD million (2021-2030)
      • 7.4.1.3. Mexico Circadian Rhythm Sleep Disorders Market Size in USD million (2021-2030)
    • 7.4.2. Europe
      • 7.4.2.1. France Circadian Rhythm Sleep Disorders Market Size in USD million (2021-2030)
      • 7.4.2.2. Germany Circadian Rhythm Sleep Disorders Market Size in USD million (2021-2030)
      • 7.4.2.3. United Kingdom Circadian Rhythm Sleep Disorders Market Size in USD million (2021-2030)
      • 7.4.2.4. Italy Circadian Rhythm Sleep Disorders Market Size in USD million (2021-2030)
      • 7.4.2.5. Spain Circadian Rhythm Sleep Disorders Market Size in USD million (2021-2030)
      • 7.4.2.6. Rest of Europe Circadian Rhythm Sleep Disorders Market Size in USD million (2021-2030)
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. China Circadian Rhythm Sleep Disorders Market Size in USD million (2021-2030)
      • 7.4.3.2. Japan Circadian Rhythm Sleep Disorders Market Size in USD million (2021-2030)
      • 7.4.3.3. India Circadian Rhythm Sleep Disorders Market Size in USD million (2021-2030)
      • 7.4.3.4. Australia Circadian Rhythm Sleep Disorders Market Size in USD million (2021-2030)
      • 7.4.3.5. South Korea Circadian Rhythm Sleep Disorders Market Size in USD million (2021-2030)
      • 7.4.3.6. Rest of Asia-Pacific Circadian Rhythm Sleep Disorders Market Size in USD million (2021-2030)
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. Middle East Circadian Rhythm Sleep Disorders Market Size in USD million (2021-2030)
      • 7.4.4.2. Africa Circadian Rhythm Sleep Disorders Market Size in USD million (2021-2030)
      • 7.4.4.3. South America Circadian Rhythm Sleep Disorders Market Size in USD million (2021-2030)

8. Circadian Rhythm Sleep Disorders Market Company and Product Profiles

  • 8.1. Koninklijke Philips N.V.
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. The Sunbox Company
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Northern Light Technologies
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Takeda Pharmaceutical Company Limited
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Teva Pharmaceutical Industries Ltd.
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Pfizer Inc.
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. VANDA PHARMACEUTICALS
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Nature's Bounty
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Verilux, Inc.
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. OLLY Vitamins & Supplements
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Pure Encapsulations, LLC
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Vespyr Brands
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. NOW FOODS
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Natrol, LLC.
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Pharmavite LLC
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. Relaxium
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. Amazon Basics
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. Future Kind
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. Apollo Light Systems
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제